SAD and MAD Study With IV and SC Doses of ARGX-117

Clinical trial NCT04532125 · COMPLETED

Trial details

NCT number: NCT04532125
Sponsor: argenx
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-08-03
Primary completion: 2022-08-26
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.